市場調査レポート
商品コード
1144284

体外診断用医薬品の世界市場 2022-2026

Global In-vitro Diagnostics Market 2022-2026

出版日: | 発行: TechNavio | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
体外診断用医薬品の世界市場 2022-2026
出版日: 2022年09月26日
発行: TechNavio
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは体外診断用医薬品の市場規模は、2022年から2026年の間に331億6000万米ドルの増加が見込まれ、予測期間中に6.89%のCAGRで成長すると予測しています。当レポートでは、体外診断用医薬品市場の全体的な分析、市場規模と予測、動向、成長促進要因・課題、約25のベンダーを網羅したベンダー分析などを提供しています。

現在の世界の市場動向と促進要因、市場全体の環境について最新の分析を提供しています。

市場は、高齢者人口の増加、慢性疾患や感染症、個別化医療への高い需要、創薬への投資の増加によって牽引されています。

本調査では、今後数年間における体外診断用医薬品市場の成長を促進する主要な理由の1つとして、体外診断用医薬品の技術的進歩を挙げています。また、先進的な治療ソリューションの世界の導入やデジタル体外診断用医薬品分野における革新は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2021
  • 市場の見通し:2021-2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第5章 テクノロジー別の市場セグメンテーション

  • 市場内訳
  • 技術別比較
  • イムノアッセイ - 市場規模と予測 2021-2026
  • 分子診断 - 市場規模と予測 2021-2026
  • 臨床化学 - 市場規模と予測 2021-2026
  • 血液学 - 市場規模と予測 2021-2026
  • その他 - 市場規模と予測 2021-2026
  • テクノロジー別の市場機会

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米 - 市場規模と予測 2021-2026
  • 欧州 - 市場規模と予測 2021-2026
  • アジア - 市場規模と予測 2021-2026
  • その他の地域(ROW) - 市場規模と予測 2021-2026
  • 米国 - 市場規模と予測 2021-2026
  • 中国 - 市場規模と予測 2021-2026
  • 日本 - 市場規模と予測 2021-2026
  • ドイツ - 市場規模と予測 2021-2026
  • カナダ - 市場規模と予測 2021-2026
  • 地域情勢別の市場機会

第8章 促進要因、課題、および動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • 混乱の状況
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • Abbott Laboratories
  • Danaher Corp.
  • DiaSorin SpA
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Ortho Clinical Diagnostics plc
  • Quest Diagnostics Inc.
  • Siemens AG
  • Sysmex Corp
  • Thermo Fisher Scientific Inc.

第11章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Technology - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Technology - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Technology
  • Exhibits27: Data Table on Comparison by Technology
  • Exhibits28: Chart on Immunoassay - Market size and forecast 2021-2026 ($ billion)
  • Exhibits29: Data Table on Immunoassay - Market size and forecast 2021-2026 ($ billion)
  • Exhibits30: Chart on Immunoassay - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Immunoassay - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
  • Exhibits33: Data Table on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
  • Exhibits34: Chart on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
  • Exhibits37: Data Table on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
  • Exhibits38: Chart on Clinical chemistry - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Clinical chemistry - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Chart on Hematology - Market size and forecast 2021-2026 ($ billion)
  • Exhibits41: Data Table on Hematology - Market size and forecast 2021-2026 ($ billion)
  • Exhibits42: Chart on Hematology - Year-over-year growth 2021-2026 (%)
  • Exhibits43: Data Table on Hematology - Year-over-year growth 2021-2026 (%)
  • Exhibits44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibits45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibits46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits47: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits48: Market opportunity by Technology ($ billion)
  • Exhibits49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits52: Chart on Geographic comparison
  • Exhibits53: Data Table on Geographic comparison
  • Exhibits54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibits55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibits56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibits59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibits60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibits63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibits64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibits67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibits68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibits71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibits72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibits79: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibits80: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibits83: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibits84: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibits87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibits88: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits90: Market opportunity By Geographical Landscape ($ billion)
  • Exhibits91: Impact of drivers and challenges in 2021 and 2026
  • Exhibits92: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits93: Overview on factors of disruption
  • Exhibits94: Impact of key risks on business
  • Exhibits95: Vendors covered
  • Exhibits96: Matrix on vendor position and classification
  • Exhibits97: Abbott Laboratories - Overview
  • Exhibits98: Abbott Laboratories - Business segments
  • Exhibits99: Abbott Laboratories - Key news
  • Exhibits100: Abbott Laboratories - Key offerings
  • Exhibits101: Abbott Laboratories - Segment focus
  • Exhibits102: Danaher Corp. - Overview
  • Exhibits103: Danaher Corp. - Business segments
  • Exhibits104: Danaher Corp. - Key news
  • Exhibits105: Danaher Corp. - Key offerings
  • Exhibits106: Danaher Corp. - Segment focus
  • Exhibits107: DiaSorin SpA - Overview
  • Exhibits108: DiaSorin SpA - Business segments
  • Exhibits109: DiaSorin SpA - Key news
  • Exhibits110: DiaSorin SpA - Key offerings
  • Exhibits111: DiaSorin SpA - Segment focus
  • Exhibits112: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits113: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits114: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits115: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits116: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits117: Illumina Inc. - Overview
  • Exhibits118: Illumina Inc. - Business segments
  • Exhibits119: Illumina Inc. - Key news
  • Exhibits120: Illumina Inc. - Key offerings
  • Exhibits121: Illumina Inc. - Segment focus
  • Exhibits122: Ortho Clinical Diagnostics plc - Overview
  • Exhibits123: Ortho Clinical Diagnostics plc - Business segments
  • Exhibits124: Ortho Clinical Diagnostics plc - Key offerings
  • Exhibits125: Ortho Clinical Diagnostics plc - Segment focus
  • Exhibits126: Quest Diagnostics Inc. - Overview
  • Exhibits127: Quest Diagnostics Inc. - Business segments
  • Exhibits128: Quest Diagnostics Inc. - Key offerings
  • Exhibits129: Quest Diagnostics Inc. - Segment focus
  • Exhibits130: Siemens AG - Overview
  • Exhibits131: Siemens AG - Business segments
  • Exhibits132: Siemens AG - Key news
  • Exhibits133: Siemens AG - Key offerings
  • Exhibits134: Siemens AG - Segment focus
  • Exhibits135: Sysmex Corp - Overview
  • Exhibits136: Sysmex Corp - Business segments
  • Exhibits137: Sysmex Corp - Key offerings
  • Exhibits138: Sysmex Corp - Segment focus
  • Exhibits139: Thermo Fisher Scientific Inc. - Overview
  • Exhibits140: Thermo Fisher Scientific Inc. - Business segments
  • Exhibits141: Thermo Fisher Scientific Inc. - Key news
  • Exhibits142: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibits143: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibits144: Inclusions checklist
  • Exhibits145: Exclusions checklist
  • Exhibits146: Currency conversion rates for US$
  • Exhibits147: Research methodology
  • Exhibits148: Validation techniques employed for market sizing
  • Exhibits149: Information sources
  • Exhibits150: List of abbreviations
目次
Product Code: IRTNTR71317

Technavio has been monitoring the in-vitro diagnostics market and it is poised to grow by $ 33.16 bn during 2022-2026, accelerating at a CAGR of 6.89% during the forecast period. Our report on the in-vitro diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing geriatric population, chronic, and infectious diseases, high demand for personalized medicine, and increasing investments in drug discovery.

The in-vitro diagnostics market analysis includes the technology segment and geographic landscape.

Technavio's in-vitro diagnostics market is segmented as below:

By Technology

  • Immunoassay
  • Molecular diagnostics
  • Clinical chemistry
  • Hematology
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the technological advances in in-vitro diagnostics as one of the prime reasons driving the in-vitro diagnostics market growth during the next few years. Also, the global adoption of advanced treatment solutions and innovations in the digital in-vitro diagnostics sector will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the in-vitro diagnostics market covers the following areas:

  • In-vitro diagnostics market sizing
  • In-vitro diagnostics market forecast
  • In-vitro diagnostics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro diagnostics market vendors that include Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc., Becton Dickinson, and Co., BGI Group, Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., Grifols SA, Illumina Inc., Ortho Clinical Diagnostics plc, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp, and Thermo Fisher Scientific Inc. Also, the in-vitro diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Technology
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Technology

  • 5.1 Market segments
  • Exhibit 24: Chart on Technology - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Technology - Market share 2021-2026 (%)
  • 5.2 Comparison by Technology
  • Exhibit 26: Chart on Comparison by Technology
  • Exhibit 27: Data Table on Comparison by Technology
  • 5.3 Immunoassay - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Immunoassay - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 29: Data Table on Immunoassay - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 30: Chart on Immunoassay - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Immunoassay - Year-over-year growth 2021-2026 (%)
  • 5.4 Molecular diagnostics - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 33: Data Table on Molecular diagnostics - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 34: Chart on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Molecular diagnostics - Year-over-year growth 2021-2026 (%)
  • 5.5 Clinical chemistry - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 37: Data Table on Clinical chemistry - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 38: Chart on Clinical chemistry - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Clinical chemistry - Year-over-year growth 2021-2026 (%)
  • 5.6 Hematology - Market size and forecast 2021-2026
  • Exhibit 40: Chart on Hematology - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 41: Data Table on Hematology - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 42: Chart on Hematology - Year-over-year growth 2021-2026 (%)
  • Exhibit 43: Data Table on Hematology - Year-over-year growth 2021-2026 (%)
  • 5.7 Others - Market size and forecast 2021-2026
  • Exhibit 44: Chart on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 45: Data Table on Others - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 46: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 47: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.8 Market opportunity by Technology
  • Exhibit 48: Market opportunity by Technology ($ billion)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 50: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 51: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 52: Chart on Geographic comparison
  • Exhibit 53: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 54: Chart on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 55: Data Table on North America - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 56: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 59: Data Table on Europe - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 60: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 63: Data Table on Asia - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 64: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 67: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 68: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 70: Chart on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 71: Data Table on US - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 72: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 China - Market size and forecast 2021-2026
  • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.9 Japan - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
  • 7.10 Germany - Market size and forecast 2021-2026
  • Exhibit 82: Chart on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 83: Data Table on Germany - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 84: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 85: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 86: Chart on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 87: Data Table on Canada - Market size and forecast 2021-2026 ($ billion)
  • Exhibit 88: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 89: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 90: Market opportunity By Geographical Landscape ($ billion)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 93: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 94: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 95: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 96: Matrix on vendor position and classification
  • 10.3 Abbott Laboratories
  • Exhibit 97: Abbott Laboratories - Overview
  • Exhibit 98: Abbott Laboratories - Business segments
  • Exhibit 99: Abbott Laboratories - Key news
  • Exhibit 100: Abbott Laboratories - Key offerings
  • Exhibit 101: Abbott Laboratories - Segment focus
  • 10.4 Danaher Corp.
  • Exhibit 102: Danaher Corp. - Overview
  • Exhibit 103: Danaher Corp. - Business segments
  • Exhibit 104: Danaher Corp. - Key news
  • Exhibit 105: Danaher Corp. - Key offerings
  • Exhibit 106: Danaher Corp. - Segment focus
  • 10.5 DiaSorin SpA
  • Exhibit 107: DiaSorin SpA - Overview
  • Exhibit 108: DiaSorin SpA - Business segments
  • Exhibit 109: DiaSorin SpA - Key news
  • Exhibit 110: DiaSorin SpA - Key offerings
  • Exhibit 111: DiaSorin SpA - Segment focus
  • 10.6 F. Hoffmann La Roche Ltd.
  • Exhibit 112: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 113: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 114: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 115: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 116: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.7 Illumina Inc.
  • Exhibit 117: Illumina Inc. - Overview
  • Exhibit 118: Illumina Inc. - Business segments
  • Exhibit 119: Illumina Inc. - Key news
  • Exhibit 120: Illumina Inc. - Key offerings
  • Exhibit 121: Illumina Inc. - Segment focus
  • 10.8 Ortho Clinical Diagnostics plc
  • Exhibit 122: Ortho Clinical Diagnostics plc - Overview
  • Exhibit 123: Ortho Clinical Diagnostics plc - Business segments
  • Exhibit 124: Ortho Clinical Diagnostics plc - Key offerings
  • Exhibit 125: Ortho Clinical Diagnostics plc - Segment focus
  • 10.9 Quest Diagnostics Inc.
  • Exhibit 126: Quest Diagnostics Inc. - Overview
  • Exhibit 127: Quest Diagnostics Inc. - Business segments
  • Exhibit 128: Quest Diagnostics Inc. - Key offerings
  • Exhibit 129: Quest Diagnostics Inc. - Segment focus
  • 10.10 Siemens AG
  • Exhibit 130: Siemens AG - Overview
  • Exhibit 131: Siemens AG - Business segments
  • Exhibit 132: Siemens AG - Key news
  • Exhibit 133: Siemens AG - Key offerings
  • Exhibit 134: Siemens AG - Segment focus
  • 10.11 Sysmex Corp
  • Exhibit 135: Sysmex Corp - Overview
  • Exhibit 136: Sysmex Corp - Business segments
  • Exhibit 137: Sysmex Corp - Key offerings
  • Exhibit 138: Sysmex Corp - Segment focus
  • 10.12 Thermo Fisher Scientific Inc.
  • Exhibit 139: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 140: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 141: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 142: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 143: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 144: Inclusions checklist
  • Exhibit 145: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 146: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 147: Research methodology
  • Exhibit 148: Validation techniques employed for market sizing
  • Exhibit 149: Information sources
  • 11.5 List of abbreviations
  • Exhibit 150: List of abbreviations